THC Financial Statements From 2010 to 2024
| THCBF Stock | USD 0 0.00 0.00% |
Check THC Biomed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among THC Biomed's main balance sheet or income statement drivers, such as , as well as many indicators such as . THC financial statements analysis is a perfect complement when working with THC Biomed Valuation or Volatility modules.
THC |
THC Biomed Intl Company Return On Equity Analysis
THC Biomed's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current THC Biomed Return On Equity | -0.41 |
Most of THC Biomed's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, THC Biomed Intl is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, THC Biomed Intl has a Return On Equity of -0.4132. This is 98.28% lower than that of the Pharmaceuticals sector and significantly lower than that of the Health Care industry. The return on equity for all United States stocks is 33.29% higher than that of the company.
THC Biomed Intl Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining THC Biomed's current stock value. Our valuation model uses many indicators to compare THC Biomed value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across THC Biomed competition to find correlations between indicators driving THC Biomed's intrinsic value. More Info.THC Biomed Intl is rated third in return on equity category among its peers. It is currently regarded as top stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the THC Biomed's earnings, one of the primary drivers of an investment's value.About THC Biomed Financial Statements
THC Biomed stakeholders use historical fundamental indicators, such as THC Biomed's revenue or net income, to determine how well the company is positioned to perform in the future. Although THC Biomed investors may analyze each financial statement separately, they are all interrelated. For example, changes in THC Biomed's assets and liabilities are reflected in the revenues and expenses on THC Biomed's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in THC Biomed Intl. Please read more on our technical analysis and fundamental analysis pages.
THC Biomed Intl Ltd. produces and sells medical and recreational cannabis in Canada. THC Biomed Intl Ltd. was founded in 2012 and is headquartered in Kelowna, Canada. Thc Biomed is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Other Information on Investing in THC Pink Sheet
THC Biomed financial ratios help investors to determine whether THC Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in THC with respect to the benefits of owning THC Biomed security.